Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2013; 19(31): 5067-5075
Published online Aug 21, 2013. doi: 10.3748/wjg.v19.i31.5067
Published online Aug 21, 2013. doi: 10.3748/wjg.v19.i31.5067
Figure 4 Validation of proteins associated with the immune response.
A: Validation by enzyme-linked immunosorbent assay showed that there were elevated levels of alpha-HS-glycoprotein in non-responders before chronic hepatitis B treatment. n = 19 gels from all patients and groups; B: Validation by immunonephelometry showed elevated levels of complement component C3c in non-responders before chronic hepatitis B treatment; C: Validation by immunonephelometry showed elevated levels of CD5 antigen-like proteins in non-responders before chronic hepatitis B treatment. SVR: Sustained virological response; NR: Non-responder.
- Citation: Kuakarn S, SomParn P, Tangkijvanich P, Mahachai V, Thongboonkerd V, Hirankarn N. Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b. World J Gastroenterol 2013; 19(31): 5067-5075
- URL: https://www.wjgnet.com/1007-9327/full/v19/i31/5067.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i31.5067